Skip to content

A clinical study on the efficacy and safety of polycentric, random, blind, and positive drugs in the parallel control of compound naphthalene in the elimination of asthenopia

A clinical study on the efficacy and safety of polycentric, random, blind, and positive drugs in the parallel control of compound naphthalene in the elimination of asthenopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17014008
Enrollment
Unknown
Registered
2017-12-17
Start date
2007-09-06
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthenopia

Interventions

experimental group:deliver compoud naphthalene to conjunctiva capsule
control group:deliver single naphthalene to conjunctiva capsule

Sponsors

Eye & ENT Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18~65 years old male and female; 2. Symptoms of asthenopia caused by various causes, and 2 or more of the symptoms listed; 3. The total score of clinical observation indicators is at least 15; 4. Volunteered to be subject, understand and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Having any eye disease that affected the clinical study; 2. Severe heart, lung, liver, renal dysfunction; 3. Pregnant and lactating women; 4. Psychopath; 5. Allergic to any known ingredient in the test drug and control drug; 7. Other drugs that may affect the evaluation of the results of this experiment are being applied throughout the body or part of the body.

Design outcomes

Primary

MeasureTime frame
vision;intraocular pressure;cornea fluorescein staining;eye tolerance;

Countries

China

Contacts

Public ContactXinghuai Sun

Eye & ENT Hospital, Shanghai Medical College, Fudan University

xhsun@shmu.edu.cn+86 64377134

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026